On Tuesday, August 6, 2025, the Ministry of Health, in collaboration with the National Vaccine Institute (NVI) and the Ghana Investment Promotion Centre (GIPC), will convene the Ghana Vaccine Manufacturing Forum at the Kempinski Hotel Gold Coast City in Accra.
The high-profile event, themed “Mobilising Sustainable Financing to Accelerate Vaccine Development and Manufacturing in Ghana: The Role of Financing Institutions and Development Partners,” aims to unite key stakeholders from government, financial institutions, pharmaceutical companies, investors, research institutions, and development partners.
In a statement released by Tony Goodman, Deputy Director and Spokesperson for the Ministry of Health, it was announced that President John Dramani Mahama will attend as the Special Guest of Honour, while the Minister for Health, Mr. Kwabena Mintah Akandoh, will serve as the Guest of Honour.
This forum arrives at a crucial juncture as Ghana reassesses and aims to enhance its capacity for vaccine research, development, and production in the wake of the COVID-19 pandemic. Although the nation boasts a solid foundation in health regulation, pharmaceutical research, and local drug production, officials stress that sustainable financing remains a significant obstacle in creating a comprehensive vaccine manufacturing ecosystem.
According to the Ministry of Health, an estimated US$2.5 billion is needed to establish an end-to-end vaccine production value chain in Ghana. The forthcoming forum seeks to mobilize the necessary funds through innovative financing models such as blended finance and Public-Private Partnerships.
Support from international partners like GIZ and the World Bank has been pivotal in progressing the agenda. GIZ, through the PharmaVax Ghana program funded by the German Development Ministry (BMZ) and the European Union, is actively collaborating with the NVI to foster pharmaceutical self-sufficiency in the region. Additionally, local manufacturers such as Atlantic Lifesciences Ltd and DEK Vaccines Ltd have inked Memoranda of Understanding with global partners to facilitate technology transfer aimed at advancing vaccine fill-and-finish operations within the country.
The forum aspires to:
Facilitate dialogue among public and private stakeholders.
Explore financing and policy strategies to attract long-term investments.
Identify regulatory mechanisms that support vaccine development.
Generate actionable proposals and partnerships to advance Ghana’s vaccine self-reliance agenda.
To ensure inclusive participation, the event will adopt a hybrid format, enabling both in-person and virtual attendance. This collaborative effort underscores Ghana’s commitment to fostering a robust vaccine manufacturing sector, enhancing health security, and becoming self-reliant in vaccine production.
Source: Apexnewsgh.com
